Draven26
Bluelighter
I am a patient that needs access to compounded hormone treatments that I can afford.
I am asking the FDA not to block patients' access to compounded hormones by not implementing recommendations of the 2020 NASEM report. The recommendations from this FDA commissioned report, if implemented, will deprive millions of patients like me from getting the treatment they need to combat life-altering symptoms that are currently managed through compounded hormone therapy.
NASEM's recommendations seek to severely restrict - or eliminate entirely- the ability of the physician to prescribe cBHT to his or her patients. In turn, the restriction on the physician's ability to prescribe cBHT would limit the patient 's choices for treatment. When a patient's choices are limited, so too is his or her path to wellness.
I therefore strongly urge the FDA to consider that patient need take priority over policymaking._id=14577
I am asking the FDA not to block patients' access to compounded hormones by not implementing recommendations of the 2020 NASEM report. The recommendations from this FDA commissioned report, if implemented, will deprive millions of patients like me from getting the treatment they need to combat life-altering symptoms that are currently managed through compounded hormone therapy.
NASEM's recommendations seek to severely restrict - or eliminate entirely- the ability of the physician to prescribe cBHT to his or her patients. In turn, the restriction on the physician's ability to prescribe cBHT would limit the patient 's choices for treatment. When a patient's choices are limited, so too is his or her path to wellness.
I therefore strongly urge the FDA to consider that patient need take priority over policymaking._id=14577
Last edited by a moderator: